IQE PLC Iqe Plc : Director Dealings

 
TIDMIQE 
 
 
   IQE plc ("IQE" or the "Company") 
 
   Director Dealings 
 
   Cardiff, UK. 7(th) August 2017: IQE plc has been informed by Dr Drew 
Nelson, CEO, that he has transferred an aggregate of 1,000,000 ordinary 
shares of 1 pence each ("Ordinary Shares") to several family members on 
4 August 2017 for nil consideration (the "Transactions"). The family 
members are not deemed to be closely associated persons ("PCA").  Dr 
Nelson's shareholding following the transfer is 27,446,913 shares 
 
   Post the Transactions, Dr Nelson's total holding comprises of 28,459,218 
Ordinary Shares (which includes 18,000,000 shares that are subject to an 
obligation to repurchase as part of a loan agreement announced on 13 
November 2014), representing 4.16% of the Company's issued share capital, 
and 3,145,433 unexercised fully vested options over Ordinary Shares. In 
addition, Dr Nelson has 7,532,962 share options, which vest in January 
2019 subject to performance criteria. 
 
   The notification set out below is provided in accordance with the 
requirements of the EU Market Abuse Regulation. 
 
   Notification of a Transaction pursuant to Article 19(1) of Regulation 
(EU) No. 596/2014 
 
 
 
 
1.  Details of the Person discharging managerial responsibilities 
     ("PDMR") / person closely associated with them ("PCA") 
a)  Name                        Dr Andrew Nelson 
2.  Reason for the notification 
a)  Position / status           CEO 
b)  Initial notification /      Initial notification 
    amendment 
3.  Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                        IQE plc 
b)  Legal Entity Identifier     213800Y33WHD3ESJJP16 
4.  Details of the transaction(s): section to be repeated 
     for (i) each type of instrument; (ii) each type of 
     transaction; (iii) each date; and (iv) each place 
     where transactions have been conducted 
a)  Description of the          Ordinary shares of 1 pence each in the Company 
    financial instrument         GB0009619924 
b)  Nature of the transaction   Transfer of Ordinary Shares to non-PCA 
c)  Price(s) and volume(s) 
                                 Price(s) Volume(s) 
                                 Nil 500,000 
                                 Nil 500,000 
d)  Aggregated information      1,000,000 Ordinary Shares 
     --    Aggregated volume     Nil cost 
 
     --    Aggregated price 
e)  Date of the transaction(s)  4 August 2017 
f)  Place of the transaction    London Stock Exchange, AIM 
 
 
 
   CONTACTS 
 
   IQE plc [phone] 
 
   Drew Nelson 
 
   Phil Rasmussen 
 
   Chris Meadows 
 
   Canaccord Genuity + 44 (0) 20 7523 8000 
 
   Simon Bridges 
 
   Henry Fitzgerald O'Connor 
 
   Richard Andrews 
 
   Peel Hunt [phone] 
 
   Euan Brown 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: IQE plc via Globenewswire 
 
 
  http://www.iqep.com 
 

(END) Dow Jones Newswires

August 07, 2017 09:00 ET (13:00 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.